-
Tumor-Infiltrating Lymphocytes May Be Future Mesothelioma Treatment
Though it is still early in the investigative process, positive results from the use of tumor-infiltrating lymphocytes on lung cancer patients may hold promise for those with malignant pleural mesothelioma.
-
Johnson & Johnson Files Lawsuit Against Mesothelioma Expert
For years, Johnson & Johnson has faced personal injury claims filed by people diagnosed with malignant mesothelioma and ovarian cancer who blame talc in the company’s cosmetic products for their illness. With 40,000 claims pending, the company pursued a controversial legal strategy: they transferred all liability for their talc-based products to a new subsidiary, then…
-
Asbestos Company’s Attempt to Remove Mesothelioma Case Denied by Court
Mesothelioma is caused by exposure to asbestos. Victims of the fatal disease often seek compensation from the companies whose negligence led to their illness. Afraid of multi-million-dollar verdicts against them, these companies use various legal maneuvers to have cases dismissed or heard in courts thought to be less sympathetic to victims. In a recent case…
-
Mesothelioma Lawsuit Against Avon Ends with Jury awarding $52.1 Million in Damages
A 76-year-old woman and her husband were awarded $52.1 million in damages by a California jury that agreed that her malignant mesothelioma was caused by exposure to asbestos in Avon cosmetic products. The jury assigned a percentage of blame to another defendant, a forklift maker for whom her husband had worked.
-
Study Links Mesothelioma Surgery Outcomes to Pre-Surgical Physical Function
In considering their patients’ options after a mesothelioma diagnosis, oncologists weigh many factors. A patient’s age is important, but so too is the type of mesothelioma they have and how far it has advanced within their body. Now a new study out of the University of Maryland has expanded this list, indicating that a patient’s…
-
Volkswagen Ordered to Pay $5.75 Million in Mesothelioma Damages
It’s been just over two years since Thomas Sorrentino was diagnosed with malignant mesothelioma, and February will mark the two-year anniversary of his death from the rare and fatal asbestos-related disease. Fortunately, he was able to give a deposition a few days before his death, and the testimony he provided was invaluable to the King…
-
Mesothelioma Patients in Rural Areas May See Higher Costs due to Medicare Cuts
Though teaching hospitals based in major metropolitan areas often deliver the most innovative care, malignant mesothelioma patients are frequently treated at community cancer clinics that are closest to their homes. The convenience of local treatment helps to preserve quality of life and can help cut costs. But Medicare’s Physician Fee Schedule (PFS) Final Rule for…
-
Mesothelioma, Asbestosis, and India’s Asbestos Timebomb
Malignant mesothelioma and other asbestos-related diseases are a global scourge, but Indian health experts warn that their country is facing a uniquely deadly future, with millions of people at risk.
-
Study Demonstrates Effectiveness of Immunotoxins in Treating Mesothelioma
Oncology researchers from the National Institutes of Health have published the results of a mesothelioma study that may prove useful in treating the rare, asbestos-related form of cancer. The group found that laboratory animal mesothelioma cells responded completely to exposure to an immunotoxin treatment. Their findings suggest that similar treatment may prove helpful in treating the…
-
Refinery Workers with Mesothelioma Seek Compensation from Hess
Seeking shelter from hundreds of asbestos exposure lawsuits filed by victims of mesothelioma, asbestos-related lung cancer, and other serious illnesses, Hess Corporation has put a subsidiary company into bankruptcy protection. In response, those victims are now redirecting their legal actions to the parent company itself.
-
Baylor Reports Positive Outcomes of Immunotherapy before Mesothelioma Surgery
Immunotherapy has proven to be among the most exciting medical breakthroughs in the treatment of malignant mesothelioma. The technology leverages the body’s own immune system to fight back against malignancy. Though much has already been learned, there is even more yet to be discovered. A study conducted by researchers from Baylor College of Medicine has…
-
Flu Poses Deadly Threat to Patients with Malignant Mesothelioma
Just as mesothelioma patients are taking a collective sigh of relief at the fading of COVID-19, health officials are sounding the alarm about this year’s flu. Those warnings are particularly important for those diagnosed with the rare and deadly form of cancer.
-
Oklahoma Man with Mesothelioma Recalls Childhood Exposure to Asbestos-Contaminated Products
Malignant mesothelioma is a rare and fatal form of cancer caused by exposure to asbestos. While most cases are traced to workplace exposure, some are connected to home chores such as laundering asbestos-contaminated work clothes, and others to living in close proximity to sites where the carcinogen was used. A recent lawsuit revealed how childhood…
-
Mesothelioma Advocacy Group Calls on Congress After Revelations of Asbestos Exposure
In response to just-published revelations of chemical company employee exposure to asbestos, the president and co-founder of mesothelioma advocacy group Asbestos Disease Awareness Organization (ADAO) has issued a statement calling on Congress to finally enact a U.S. ban on the lethal material. According to Linda Reinstein, “Congress knows what it must do, and these heartbreaking personal stories…
-
Caring for a Mesothelioma Patient Creates Significant Stress. A New Tool Can Help
Whether the mesothelioma patient you’re caring for is a family member, friend, neighbor, or client, the responsibility creates intense levels of stress. Now a group of occupational medicine researchers in Rome has developed a new tool to gauge the extent of that psychological pain, facilitating faster relief for those who need it.
-
Peritoneal Mesothelioma Survival Extended by Academic Medical Center Care
Once diagnosed with malignant peritoneal mesothelioma, patients must make an important decision about where to seek care. For many, the natural choice is the hospital closest to their home and the comfort provided by family and friends. Others seek the state-of-the-art care that’s only available at academic medical centers. A recent study shows that though…
-
Navy Captain’s Expert Witness Testimony at Issue in Mesothelioma Lawsuit
When Arnold Pritt was diagnosed with malignant mesothelioma, he and his wife Ruth filed product liability claims against multiple defendants, including John Crane, Inc. They blame each for having exposed him to asbestos when he served in the Navy aboard the USS Purdy from December 1961 to August 1964. When expert witnesses for both sides…
-
Two Studies Confirm Usefulness of CT Technology in Mesothelioma Diagnosis
When evaluating treatment options for malignant pleural and peritoneal mesothelioma, physicians rely on several different diagnostic tests to guide their decisions. The more they know about the type and extent of tumor infiltration, the better they can assess how best to help their patient. Two recent studies conducted in the United States and Switzerland assessed…
-
Asbestos Company Fails in Effort to Try Mesothelioma Case in Federal Court
When a mesothelioma victim pursues legal justice against the companies that exposed them to asbestos, they know the battle will be long and hard. Asbestos companies use every possible legal argument to have cases dismissed or heard in industry-friendly courts, and that is what happened to Ethel Tabor, a victim whose exposure to asbestos on…
-
Study on Current Mesothelioma Patients Shows Effectiveness of Neoadjuvant Chemotherapy/Surgery Combination
The challenges of treating malignant mesothelioma are well known. The rare and fatal form of cancer is notoriously resistant to traditional protocols, and historically most patients die within a year of their diagnosis. But a recent study conducted by researchers in Japan has shown that administering chemotherapy prior to surgery is an extremely effective option…
